Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346926

Medchemexpress LLC L-803087 | 217480-26-7 | 99.7% | 485.53 | 1 MG
SDP

Catalog No. 5000346926
Encompass_Preferred

L-803087 is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM. It is >280-fold more selective than other somatostatin receptors. This compound facilitates AMPA-mediated hippocampal synaptic responses in vitro and increases kainate-induced seizures in mice.

  • Potent and selective somatostatin sst4 receptor agonist.
  • Greater than 280-fold higher selectivity for sst4 receptor compared to other somatostatin receptors.
  • Facilitates AMPA-mediated hippocampal synaptic responses in vitro.
  • Increases kainate-induced seizures in mice.
  • Does not inhibit secretion of growth hormone, insulin, or glucagon.

Catalog No. 50-003-46926 Supplier Medchemexpress LLC Supplier No. HY10849750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

L-803087 is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM. It is >280-fold more selective than other somatostatin receptors. This compound facilitates AMPA-mediated hippocampal synaptic responses in vitro and increases kainate-induced seizures in mice.

  • Potent and selective somatostatin sst4 receptor agonist.
  • Greater than 280-fold higher selectivity for sst4 receptor compared to other somatostatin receptors.
  • Facilitates AMPA-mediated hippocampal synaptic responses in vitro.
  • Increases kainate-induced seizures in mice.
  • Does not inhibit secretion of growth hormone, insulin, or glucagon.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.